Liminal Biosciences Inc. (LMNL) Social Stream
Liminal BioSciences Inc (LMNL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Liminal BioSciences Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $4.5 | $2.3 | $3.1 | $1.6 | 93.75% |
The Trend in the Analyst Price Target
LMNL's average price target has moved up $0.09 over the prior 2 days.
LMNL reports an average of 91.44% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 4 | 4.49836 | 2.29916 | 3.60037 | 2.52 | 42.87% |
| 2021-09-20 | 4 | 4.55875 | 2.33003 | 3.64870 | 2.52 | 44.79% |
| 2021-09-20 | 4 | 4.59382 | 2.34795 | 3.67677 | 2.52 | 45.9% |
| 2021-09-20 | 4 | 4.59672 | 2.34943 | 3.67909 | 2.52 | 46% |
| 2021-09-20 | 4 | 4.60909 | 2.35576 | 3.68899 | 2.52 | 46.39% |
| 2021-09-20 | 4 | 4.59270 | 2.34738 | 3.67588 | 2.52 | 45.87% |
| 2021-05-27 | 4 | 22.09544 | 2.81215 | 9.99288 | 4.23 | 136.24% |
| 2021-05-27 | 4 | 21.94338 | 2.79279 | 9.92411 | 4.23 | 134.61% |
| 2021-05-27 | 4 | 21.70496 | 2.76245 | 9.81628 | 4.23 | 132.06% |
| 2021-05-27 | 4 | 21.65459 | 2.75604 | 9.79350 | 4.23 | 131.52% |
| 2021-05-27 | 4 | 21.43579 | 2.72819 | 9.69455 | 4.23 | 129.19% |
| 2021-05-27 | 4 | 21.15995 | 2.69308 | 9.56980 | 4.23 | 126.24% |
| 2021-05-27 | 4 | 21.23538 | 2.70268 | 9.60391 | 4.23 | 127.04% |
| 2020-12-09 | 0 | 16.49348 | 4.63879 | 10.56538 | 4.27 | 147.43% |
| 2020-12-09 | 2 | 16.49348 | 4.63879 | 10.56538 | 4.27 | 147.43% |
| 2020-12-09 | 0 | 20.66880 | 5.81310 | 13.24000 | 4.27 | 210.07% |
| 2020-12-09 | 2 | 20.66880 | 5.81310 | 13.24000 | 4.27 | 210.07% |
| 2020-12-09 | 0 | 16.47350 | 4.63317 | 10.55258 | 4.27 | 147.13% |
| 2020-12-09 | 2 | 16.47350 | 4.63317 | 10.55258 | 4.27 | 147.13% |
LMNL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.5 | 0 | 0 | 3 | 1 | 1 | 4 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The average analyst price target of LMNL is higher than 2.09% of all US stocks.
- LMNL has a less variance in analysts' estimates than 12.13% of all US stocks.
- Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is greater than 82.81% of all US stocks.
- Liminal BioSciences Inc's number of analysts covering the stock is greater than 33.17% of Pharmaceutical Products stocks.
Stocks similar to Liminal BioSciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENDP, ANAB and ADAP.
Is LMNL a Buy, Hold or Sell? See the POWR Ratings now!